GlassScriptPhysician profile
Napoleon P Roux
NPI 1659591022
$3,858.64
in general payments reported to CMS, 2019-2025
14 companies · $395 in 2025
The $395 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $46.27 · 2021: $1,195 · 2022: $253 · 2023: $782 · 2024: $1,050 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,226.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $929.20 | 2021-2025 | General - Pain Management, Intracept |
| Medtronic, INC. | $840.99 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $660.38 | 2021-2024 | Eterna, Proclaim |
| Saluda Medical Americas, INC. | $548.96 | 2021-2023 | Evoke Scs |
| Painteq LLC | $196.30 | 2023 | Painteq |
| Nevro Corp. | $137.62 | 2019 | |
| Spr Therapeutics, INC | $129.35 | 2023 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2024 | Ajovy |
| Vertos Medical, INC. | $118.55 | 2021 | |
| Relievant Medsystems, INC. | $58.83 | 2021 | |
| Medtronic USA, INC. | $46.27 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $32.10 | 2025 | |
| Qol Medical, LLC | $19.37 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.73 | 2024 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Napoleon Roux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.